Cloonan Michael
Insider CIK 1704336 · BLUE Director · SAGE Chief Business Officer · SION President & CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SION Sionna Therapeutics, Inc. | D To issuer deriv | 2026-09-17 | 2026-09-18 | 436,100 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award deriv | 2026-09-17 | 2026-09-18 | 436,100 | — | $0 | 436,100 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award | 2026-09-17 | 2026-09-18 | 109,025 | — | $0 | 765,393 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award | 2026-09-17 | 2026-09-18 | 109,025 | — | $0 | 656,368 | SEC↗ |
| SION Sionna Therapeutics, Inc. | D To issuer deriv | 2026-09-17 | 2026-09-18 | 436,100 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award deriv | 2026-09-17 | 2026-09-18 | 436,100 | — | $0 | 436,100 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award | 2026-09-17 | 2026-09-18 | 109,025 | — | $0 | 765,393 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award | 2026-09-17 | 2026-09-18 | 109,025 | — | $0 | 656,368 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 436,100 | — | $0 | 436,100 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise deriv | 2025-10-21 | 2025-10-22 | 13,324 | — | $0 | 139,618 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise deriv | 2025-10-21 | 2025-10-22 | 30,049 | — | $0 | 109,569 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise deriv | 2025-10-21 | 2025-10-22 | 33,532 | — | $0 | 53,142 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise deriv | 2025-10-21 | 2025-10-22 | 22,895 | — | $0 | 86,674 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise | 2025-10-21 | 2025-10-22 | 30,049 | $6.11 | $183.6K | 577,392 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-21 | 2025-10-22 | 13,324 | $34.44 | $458.9K | 547,343 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise | 2025-10-21 | 2025-10-22 | 13,324 | $6.11 | $81.4K | 560,667 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-21 | 2025-10-22 | 33,532 | $37.31 | $1.25M | 547,343 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise | 2025-10-21 | 2025-10-22 | 33,532 | $6.11 | $204.9K | 580,875 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-21 | 2025-10-22 | 22,895 | $36.60 | $838.0K | 547,343 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise | 2025-10-21 | 2025-10-22 | 22,895 | $6.11 | $139.9K | 570,238 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-21 | 2025-10-22 | 30,049 | $35.63 | $1.07M | 547,343 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise deriv | 2025-10-16 | 2025-10-17 | 200 | — | $0 | 152,942 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise deriv | 2025-10-16 | 2025-10-17 | 10,225 | — | $0 | 153,142 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise | 2025-10-16 | 2025-10-17 | 200 | $6.11 | $1.2K | 547,543 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-16 | 2025-10-17 | 200 | $34.00 | $6.8K | 547,343 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-16 | 2025-10-17 | 10,225 | $31.46 | $321.7K | 547,343 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise | 2025-10-16 | 2025-10-17 | 10,225 | $6.11 | $62.5K | 557,568 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise deriv | 2025-10-15 | 2025-10-17 | 14,775 | — | $0 | 163,367 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise | 2025-10-15 | 2025-10-17 | 14,775 | $6.11 | $90.3K | 562,118 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-17 | 14,775 | $31.11 | $459.7K | 547,343 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise deriv | 2025-09-29 | 2025-09-30 | 7,793 | — | $0 | 178,142 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-09-29 | 2025-09-30 | 7,793 | $29.70 | $231.5K | 547,343 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise | 2025-09-29 | 2025-09-30 | 7,793 | $6.11 | $47.6K | 555,136 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise deriv | 2025-09-26 | 2025-09-30 | 17,207 | — | $0 | 185,935 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise | 2025-09-26 | 2025-09-30 | 17,207 | $6.11 | $105.1K | 564,550 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-09-26 | 2025-09-30 | 17,207 | $28.85 | $496.4K | 547,343 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise deriv | 2025-08-27 | 2025-08-28 | 7,426 | — | $0 | 203,142 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-08-27 | 2025-08-28 | 7,426 | $25.01 | $185.7K | 547,343 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise | 2025-08-27 | 2025-08-28 | 7,426 | $6.11 | $45.4K | 554,769 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise deriv | 2025-08-26 | 2025-08-28 | 17,574 | — | $0 | 210,568 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise | 2025-08-26 | 2025-08-28 | 17,574 | $6.11 | $107.4K | 564,917 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-08-26 | 2025-08-28 | 17,574 | $24.96 | $438.6K | 547,343 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise deriv | 2025-08-20 | 2025-08-21 | 25,000 | — | $0 | 228,142 | SEC↗ |
| SION Sionna Therapeutics, Inc. | M Exercise | 2025-08-20 | 2025-08-21 | 25,000 | $6.11 | $152.8K | 572,343 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-08-20 | 2025-08-21 | 25,000 | $22.75 | $568.8K | 547,343 | SEC↗ |
| BLUE bluebird bio, Inc. | D To issuer | 2025-06-02 | 2025-06-03 | 1,867 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award deriv | 2025-02-06 | 2025-02-10 | 450,252 | — | $0 | 450,252 | SEC↗ |
| BLUE bluebird bio, Inc. | A Award | 2024-09-30 | 2024-10-02 | 37,350 | — | $0 | 37,350 | SEC↗ |
| BLUE bluebird bio, Inc. | A Award deriv | 2024-06-20 | 2024-06-24 | 74,775 | — | $0 | 74,775 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2021-02-10 | 2021-02-12 | 19,000 | — | $0 | 19,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2020-05-01 | 2020-05-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2020-04-28 | 2020-04-30 | 9,450 | — | $0 | 9,450 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2020-02-12 | 2020-02-14 | 22,500 | — | $0 | 22,500 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | F Tax w/h | 2019-07-25 | 2019-07-29 | 1,088 | $161.38 | $175.6K | 2,102 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award | 2019-07-25 | 2019-07-29 | 2,450 | — | $0 | 3,190 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | M Exercise deriv | 2019-05-22 | 2019-05-24 | 25,000 | — | $0 | 160,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | S Sale | 2019-05-22 | 2019-05-24 | 25,000 | $175.00 | $4.38M | 461 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | M Exercise | 2019-05-22 | 2019-05-24 | 25,000 | $73.43 | $1.84M | 25,461 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2019-02-13 | 2019-02-15 | 24,500 | — | $0 | 24,500 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2018-04-02 | 2018-04-04 | 36,000 | — | $0 | 36,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2017-05-01 | 2017-05-04 | 185,000 | — | $0 | 185,000 | SEC↗ |